Advertisement

Bioavailability and Metabolism of Vitamin E

  • Sandra Flory
  • Marc Birringer
  • Jan FrankEmail author
Chapter
Part of the Nutrition and Health book series (NH)

Abstract

Dietary vitamin E is ingested from plant foods, fortified foods, and/or dietary supplements as a mixture of the four tocopherols and the four tocotrienols and to a lesser extent tocomonoenols. Natural sources of vitamin E and food supplements contain both free and esterified forms of vitamin E. Vitamin E has a high bioavailability of ca. 50–80% and follows the general absorptive route of dietary fats. Vitamin E is absorbed even in the absence of dietary lipids, but its uptake in the small intestine can be enhanced by simultaneous fat consumption. There is no discrimination between all congeners during absorption, but the liver preferentially incorporates α-tocopherol into lipoproteins that are released into the bloodstream for distribution of lipids to peripheral tissues. The enzymatic degradation of vitamin E to its short-chain metabolites, destined for urinary excretion, in the small intestine and liver is the most important factor regulating the retention of the different vitamin E congeners in the organism. In the liver, the cytosolic α-tocopherol transfer protein is required for the secretion of vitamin E into the blood and appears to limit the excretion of mainly α-tocopherol, but to a smaller extent also the non-α-tocopherol congeners, from the body, thus making sure that sufficient vitamin E is retained for its essential biological functions.

Keywords

Absorption Bioavailability Cytochrome P450 Excretion Metabolism Regulation Tocopherols Vitamin E 

References

  1. 1.
    Krauß S, Darwisch V, Vetter W. Occurrence of tocopheryl fatty acid esters in vegetables and their non-digestibility by artificial digestion juices. Sci Rep. 2018;8:7657.  https://doi.org/10.1038/s41598-018-25997-2.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    MACMAHON MT, NEALE G. The absorption of à-tocopherol in control subjects and in patients with intestinal malabsorption. Clin Sci. 1970;38:197–210.CrossRefGoogle Scholar
  3. 3.
    Novotny JA, Fadel JG, Holstege DM, Furr HC, Clifford AJ. This kinetic, bioavailability, and metabolism study of RRR-α-tocopherol in healthy adults suggests lower intake requirements than previous estimates. J Nutr. 2012;142:2105–11.  https://doi.org/10.3945/jn.112.166462.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Nagy K, Ramos L, Courtet-Compondu M-C, Braga-Lagache S, Redeuil K, Lobo B, et al. Double-balloon jejunal perfusion to compare absorption of vitamin E and vitamin E acetate in healthy volunteers under maldigestion conditions. Eur J Clin Nutr. 2013;67:202–6.  https://doi.org/10.1038/ejcn.2012.183.CrossRefPubMedGoogle Scholar
  5. 5.
    Bruno RS, Leonard SW, Park S-I, Zhao Y, Traber MG. Human vitamin E requirements assessed with the use of apples fortified with deuterium-labeled alpha-tocopheryl acetate. Am J Clin Nutr. 2006;83:299–304.  https://doi.org/10.1093/ajcn/83.2.299.CrossRefPubMedGoogle Scholar
  6. 6.
    Jeanes YM, Hall WL, Ellard S, Lee E, Lodge JK. The absorption of vitamin E is influenced by the amount of fat in a meal and the food matrix. BJN. 2004;92:575.  https://doi.org/10.1079/BJN20041249.CrossRefGoogle Scholar
  7. 7.
    Reboul E. Vitamin E bioavailability: mechanisms of intestinal absorption in the spotlight. Antioxidants (Basel). 2017.  https://doi.org/10.3390/antiox6040095.
  8. 8.
    Parks E, Traber MG. Mechanisms of vitamin E regulation: research over the past decade and focus on the future. Antioxid Redox Signal. 2000;2:405–12.  https://doi.org/10.1089/15230860050192189.CrossRefPubMedGoogle Scholar
  9. 9.
    Schmölz L, Birringer M, Lorkowski S, Wallert M. Complexity of vitamin E metabolism. World J Biol Chem. 2016;7:14–43.  https://doi.org/10.4331/wjbc.v7.i1.14.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Yamanashi Y, Takada T, Kurauchi R, Tanaka Y, Komine T, Suzuki H. Transporters for the intestinal absorption of cholesterol, vitamin E, and vitamin K. J Atheroscler Thromb. 2017;24:347–59.  https://doi.org/10.5551/jat.RV16007.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Goncalves A, Roi S, Nowicki M, Niot I, Reboul E. Cluster-determinant 36 (CD36) impacts on vitamin E postprandial response. Mol Nutr Food Res. 2014;58:2297–306.  https://doi.org/10.1002/mnfr.201400339.CrossRefPubMedGoogle Scholar
  12. 12.
    Azzi A, Stocker A. Vitamin E: non-antioxidant roles. Prog Lipid Res. 2000;39:231–55.  https://doi.org/10.1016/S0163-7827(00)00006-0.CrossRefPubMedGoogle Scholar
  13. 13.
    Kayden HJ, Traber MG. Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans. J Lipid Res. 1993;34:343–58.PubMedGoogle Scholar
  14. 14.
    Chung S, Ghelfi M, Atkinson J, Parker R, Qian J, Carlin C, Manor D. Vitamin E and phosphoinositides regulate the intracellular localization of the hepatic α-tocopherol transfer protein. J Biol Chem. 2016;291:17028–39.  https://doi.org/10.1074/jbc.M116.734210.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Qian J, Morley S, Wilson K, Nava P, Atkinson J, Manor D. Intracellular trafficking of vitamin E in hepatocytes: the role of tocopherol transfer protein. J Lipid Res. 2005;46:2072–82.  https://doi.org/10.1194/jlr.M500143-JLR200.CrossRefPubMedGoogle Scholar
  16. 16.
    Horiguchi M, Arita M, Kaempf-Rotzoll DE, Tsujimoto M, Inoue K, Arai H. pH-dependent translocation of alpha-tocopherol transfer protein (alpha-TTP) between hepatic cytosol and late endosomes. Genes Cells. 2003;8:789–800.  https://doi.org/10.1046/j.1365-2443.2003.00676.x.CrossRefPubMedGoogle Scholar
  17. 17.
    Kono N, Ohto U, Hiramatsu T, Urabe M, Uchida Y, Satow Y, Arai H. Impaired α-TTP-PIPs interaction underlies familial vitamin E deficiency. Science. 2013;340:1106–10.  https://doi.org/10.1126/science.1233508.CrossRefPubMedGoogle Scholar
  18. 18.
    Sontag TJ, Parker RS. Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J Biol Chem. 2002;277:25290–6.  https://doi.org/10.1074/jbc.M201466200.CrossRefPubMedGoogle Scholar
  19. 19.
    Grebenstein N, Schumacher M, Graeve L, Frank J. α-Tocopherol transfer protein is not required for the discrimination against γ-tocopherol in vivo but protects it from side-chain degradation in vitro. Mol Nutr Food Res. 2014;58:1052–60.  https://doi.org/10.1002/mnfr.201300756.CrossRefPubMedGoogle Scholar
  20. 20.
    Zingg J-M. Vitamin E: an overview of major research directions. Mol Asp Med. 2007;28:400–22.  https://doi.org/10.1016/j.mam.2007.05.004.CrossRefGoogle Scholar
  21. 21.
    Simon EJ, Eisengaet A, Sundheim L, Milhorat AT. Purification and characterization of urinary metabolites of α-tocopherol. J Biol Chem. 1956;221:807–17.PubMedGoogle Scholar
  22. 22.
    Chiku S, Hamamura K, Nakamura T. Novel urinary metabolite of d-delta-tocopherol in rats. J Lipid Res. 1984;25:40–8.PubMedGoogle Scholar
  23. 23.
    Bardowell SA, Ding X, Parker RS. Disruption of P450-mediated vitamin E hydroxylase activities alters vitamin E status in tocopherol supplemented mice and reveals extra-hepatic vitamin E metabolism. J Lipid Res. 2012;53:2667–76.  https://doi.org/10.1194/jlr.M030734.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Parker RS, Sontag TJ, Swanson JE, McCormick CC. Discovery, characterization, and significance of the cytochrome P450 omega-hydroxylase pathway of vitamin E catabolism. Ann N Y Acad Sci. 2004;1031:13–21.  https://doi.org/10.1196/annals.1331.002.CrossRefPubMedGoogle Scholar
  25. 25.
    Birringer M, Drogan D, Brigelius-Flohe R. Tocopherols are metabolized in HepG2 cells by side chain ω-oxidation and consecutive β-oxidation. Free Radic Biol Med. 2001;31:226–32.  https://doi.org/10.1016/S0891-5849(01)00574-3.CrossRefPubMedGoogle Scholar
  26. 26.
    Bardowell SA, Duan F, Manor D, Swanson JE, Parker RS. Disruption of mouse cytochrome p450 4f14 (Cyp4f14 gene) causes severe perturbations in vitamin E metabolism. J Biol Chem. 2012;287:26077–86.  https://doi.org/10.1074/jbc.M112.373597.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Yang Z, Lee M-J, Zhao Y, Yang CS. Metabolism of tocotrienols in animals and synergistic inhibitory actions of tocotrienols with atorvastatin in cancer cells. Genes Nutr. 2012;7:11–8.  https://doi.org/10.1007/s12263-011-0233-y.CrossRefPubMedGoogle Scholar
  28. 28.
    Zhao Y, Lee M-J, Cheung C, Ju J-H, Chen Y-K, Liu B, et al. Analysis of multiple metabolites of tocopherols and tocotrienols in mice and humans. J Agric Food Chem. 2010;58:4844–52.  https://doi.org/10.1021/jf904464u.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Sontag TJ, Parker RS. Influence of major structural features of tocopherols and tocotrienols on their omega-oxidation by tocopherol-omega-hydroxylase. J Lipid Res. 2007;48:1090–8.  https://doi.org/10.1194/jlr.M600514-JLR200.CrossRefPubMedGoogle Scholar
  30. 30.
    Birringer M, Pfluger P, Kluth D, Landes N, Brigelius-Flohé R. Identities and differences in the metabolism of tocotrienols and tocopherols in HepG2 cells. J Nutr. 2002;132:3113–8.  https://doi.org/10.1093/jn/131.10.3113.CrossRefPubMedGoogle Scholar
  31. 31.
    Lodge JK, Traber MG, Elsner A, Brigelius-Flohé R. A rapid method for the extraction and determination of vitamin E metabolites in human urine. J Lipid Res. 2000;41:148–54.PubMedGoogle Scholar
  32. 32.
    Kiyose C, Ueda T. Distribution and metabolism of tocopherols and tocotrienols in vivo. J Clin Biochem Nutr. 2004;35:47–52.  https://doi.org/10.3164/jcbn.35.47.CrossRefGoogle Scholar
  33. 33.
    Parker RS, Sontag TJ, Swanson JE. Cytochrome P4503A-dependent metabolism of tocopherols and inhibition by sesamin. Biochem Biophys Res Commun. 2000;277:531–4.  https://doi.org/10.1006/bbrc.2000.3706.CrossRefPubMedGoogle Scholar
  34. 34.
    Landes N, Pfluger P, Kluth D, Birringer M, Rühl R, Böl G-F, et al. Vitamin E activates gene expression via the pregnane X receptor. Biochem Pharmacol. 2003;65:269–73.  https://doi.org/10.1016/S0006-2952(02)01520-4.CrossRefPubMedGoogle Scholar
  35. 35.
    Zhou C, Tabb MM, Sadatrafiei A, Grün F, Blumberg B. Tocotrienols activate the steroid and xenobiotic receptor, SXR, and selectively regulate expression of its target genes. Drug Metab Dispos. 2004;32:1075–82.  https://doi.org/10.1124/dmd.104.000299.CrossRefPubMedGoogle Scholar
  36. 36.
    Podszun MC, Jakobi M, Birringer M, Weiss J, Frank J. The long chain α–tocopherol metabolite α-13′-COOH and γ-tocotrienol induce P-glycoprotein expression and activity by activation of the pregnane X receptor in the intestinal cell line LS 180. Mol Nutr Food Res.  https://doi.org/10.1002/mnfr.201600605.
  37. 37.
    Podszun MC, Grebenstein N, Spruss A, Schlueter T, Kremoser C, Bergheim I, Frank J. Dietary alpha-tocopherol and atorvastatin reduce high-fat-induced lipid accumulation and down-regulate CD36 protein in the liver of guinea pigs. J Nutr Biochem. 2014;25:573–9.  https://doi.org/10.1016/j.jnutbio.2014.01.008.CrossRefPubMedGoogle Scholar
  38. 38.
    Mustacich DJ, Gohil K, Bruno RS, Yan M, Leonard SW, Ho E, et al. Alpha-tocopherol modulates genes involved in hepatic xenobiotic pathways in mice. J Nutr Biochem. 2009;20:469–76.  https://doi.org/10.1016/j.jnutbio.2008.05.007.CrossRefPubMedGoogle Scholar
  39. 39.
    Kluth D, Landes N, Pfluger P, Müller-Schmehl K, Weiss K, Bumke-Vogt C, et al. Modulation of Cyp3a11 mRNA expression by alpha-tocopherol but not gamma-tocotrienol in mice. Free Radic Biol Med. 2005;38:507–14.  https://doi.org/10.1016/j.freeradbiomed.2004.11.010.CrossRefPubMedGoogle Scholar
  40. 40.
    Hundhausen C, Frank JAN, Rimbach G, Stoecklin E, Muller PY, Barella L. Effect of vitamin E on cytochrome P450 mRNA levels in cultured hepatocytes (HepG2) and in rat liver. Cancer Genomics Proteomics. 2006;3:183–90.Google Scholar
  41. 41.
    Podszun MC, Grebenstein N, Hofmann U, Frank J. High-dose supplementation with natural α-tocopherol does neither alter the pharmacodynamics of atorvastatin nor its phase I metabolism in guinea pigs. Toxicol Appl Pharmacol. 2013;266:452–8.  https://doi.org/10.1016/j.taap.2012.11.018.CrossRefPubMedGoogle Scholar
  42. 42.
    Mustacich DJ, Leonard SW, Devereaux MW, Sokol RJ, Traber MG. Alpha-tocopherol regulation of hepatic cytochrome P450s and ABC transporters in rats. Free Radic Biol Med. 2006;41:1069–78.  https://doi.org/10.1016/j.freeradbiomed.2006.06.022.CrossRefPubMedGoogle Scholar
  43. 43.
    Leonard SW, Joss JD, Mustacich DJ, Blatt DH, Lee YS, Traber MG. Effects of vitamin E on cholesterol levels of hypercholesterolemic patients receiving statins. Am J Health Syst Pharm. 2007;64:2257–66.  https://doi.org/10.2146/ajhp070041.CrossRefPubMedGoogle Scholar
  44. 44.
    Clarke MW, Burnett JR, Wu JHY, Hodgson JM, Ledowski T, Puddey IB, Croft KD. Vitamin E supplementation and hepatic drug metabolism in humans. J Cardiovasc Pharmacol. 2009;54:491–6.  https://doi.org/10.1097/FJC.0b013e3181bfae18.CrossRefPubMedGoogle Scholar
  45. 45.
    Jiang Q, Christen S, Shigenaga MK, Ames BN. Gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr. 2001;74:714–22.  https://doi.org/10.1093/ajcn/74.6.714.CrossRefPubMedGoogle Scholar
  46. 46.
    Frank J, Lee S, Leonard SW, Atkinson JK, Kamal-Eldin A, Traber MG. Sex differences in the inhibition of gamma-tocopherol metabolism by a single dose of dietary sesame oil in healthy subjects. Am J Clin Nutr. 2008;87:1723–9.  https://doi.org/10.1093/ajcn/87.6.1723.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Swanson JE, Ben RN, Burton GW, Parker RS. Urinary excretion of 2,7,8-trimethyl-2-(β-carboxyethyl)-6-hydroxychroman is a major route of elimination of γ-tocopherol in humans. J Lipid Res. 1999;40:665–71.PubMedGoogle Scholar
  48. 48.
    Schuelke M, Elsner A, Finckh B, Kohlschütter A, Hübner C, Brigelius-Flohé R. Urinary α-tocopherol metabolites in α-tocopherol transfer protein-deficient patients. J Lipid Res. 2000;41:1543–51.PubMedGoogle Scholar
  49. 49.
    Traber MG, Elsner A, Brigelius-Flohé R. Synthetic as compared with natural vitamin E is preferentially excreted as α-CEHC in human urine: studies using deuterated α-tocopheryl acetates. FEBS Lett. 1998;437:145–8.  https://doi.org/10.1016/S0014-5793(98)01210-1.CrossRefPubMedGoogle Scholar
  50. 50.
    Hosomi A, Arita M, Sato Y, Kiyose C, Ueda T, Igarashi O, et al. Affinity for α-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett. 1997;409:105–8.  https://doi.org/10.1016/S0014-5793(97)00499-7.CrossRefPubMedGoogle Scholar
  51. 51.
    Traber MG, Siddens LK, Leonard SW, Schock B, Gohil K, Krueger SK, et al. Alpha-tocopherol modulates Cyp3a expression, increases gamma-CEHC production, and limits tissue gamma-tocopherol accumulation in mice fed high gamma-tocopherol diets. Free Radic Biol Med. 2005;38:773–85.  https://doi.org/10.1016/j.freeradbiomed.2004.11.027.CrossRefPubMedGoogle Scholar
  52. 52.
    Parker RS, McCormick CC. Selective accumulation of alpha-tocopherol in Drosophila is associated with cytochrome P450 tocopherol-omega-hydroxylase activity but not alpha-tocopherol transfer protein. Biochem Biophys Res Commun. 2005;338:1537–41.  https://doi.org/10.1016/j.bbrc.2005.10.124.CrossRefPubMedGoogle Scholar
  53. 53.
    Terasawa Y, Ladha Z, Leonard SW, Morrow JD, Newland D, Sanan D, et al. Increased atherosclerosis in hyperlipidemic mice deficient in alpha -tocopherol transfer protein and vitamin E. Proc Natl Acad Sci U S A. 2000;97:13830–4.  https://doi.org/10.1073/pnas.240462697.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Grau A, Ortiz A. Dissimilar protection of tocopherol isomers against membrane hydrolysis by phospholipase A2. Chem Phys Lipids. 1998;91:109–18.  https://doi.org/10.1016/S0009-3084(97)00101-1.CrossRefPubMedGoogle Scholar
  55. 55.
    Frank J. Beyond vitamin E supplementation: an alternative strategy to improve vitamin E status. J Plant Physiol. 2005;162:834–43.  https://doi.org/10.1016/j.jplph.2005.04.017.CrossRefPubMedGoogle Scholar
  56. 56.
    Ross AB, Chen Y, Frank J, Swanson JE, Parker RS, Kozubek A, et al. Cereal alkylresorcinols elevate gamma-tocopherol levels in rats and inhibit gamma-tocopherol metabolism in vitro. J Nutr. 2004;134:506–10.  https://doi.org/10.1093/jn/134.3.506.CrossRefPubMedGoogle Scholar
  57. 57.
    Ikeda S, Tohyama T, Yamashita K. Dietary sesame seed and its lignans inhibit 2,7,8-trimethyl- 2(2′-carboxyethyl)-6-hydroxychroman excretion into urine of rats fed gamma-tocopherol. J Nutr. 2002;132:961–6.  https://doi.org/10.1093/jn/132.5.961.CrossRefPubMedGoogle Scholar
  58. 58.
    Kamal-Eldin A, Pettersson D, Appelqvist LA. Sesamin (a compound from sesame oil) increases tocopherol levels in rats fed ad libitum. Lipids. 1995;30:499–505.CrossRefGoogle Scholar
  59. 59.
    Kamal-Eldin A, Frank J, Razdan A, Tengblad S, Basu S, Vessby B. Effects of dietary phenolic compounds on tocopherol, cholesterol, and fatty acids in rats. Lipids. 2000;35:427–35.  https://doi.org/10.1007/s11745-000-541-y.CrossRefPubMedGoogle Scholar
  60. 60.
    Yamashita K, Iizuka Y, Imai T, Namiki M. Sesame seed and its lignans produce marked enhancement of vitamin E activity in rats fed a low α-tocopherol diet. Lipids. 1995;30:1019–28.  https://doi.org/10.1007/BF02536287.CrossRefPubMedGoogle Scholar
  61. 61.
    Yamashita K, Ikeda S, Iizuka Y, Ikeda I. Effect of sesaminol on plasma and tissue α-tocopherol and α-tocotrienol concentrations in rats fed a vitamin E concentrate rich in tocotrienols. Lipids. 2002;37:351–8.  https://doi.org/10.1007/s11745-002-0902-6.CrossRefPubMedGoogle Scholar
  62. 62.
    Hanzawa F, Nomura S, Sakuma E, Uchida T, Ikeda S. Dietary sesame seed and its lignan, sesamin, increase tocopherol and phylloquinone concentrations in male rats. J Nutr. 2013;143:1067–73.  https://doi.org/10.3945/jn.113.176636.CrossRefPubMedGoogle Scholar
  63. 63.
    Cooney RV, Custer LJ, Okinaka L, Franke AA. Effects of dietary sesame seeds on plasma tocopherol levels. Nutr Cancer. 2001;39:66–71.  https://doi.org/10.1207/S15327914nc391_9.CrossRefPubMedGoogle Scholar
  64. 64.
    Frank J, Kamal-Eldin A, Traber MG. Consumption of sesame oil muffins decreases the urinary excretion of gamma-tocopherol metabolites in humans. Ann N Y Acad Sci. 2004;1031:365–7.  https://doi.org/10.1196/annals.1331.046.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Institute of Nutritional SciencesUniversity of HohenheimStuttgartGermany
  2. 2.University of Applied Sciences FuldaNutritional, Food and Consumer SciencesFuldaGermany

Personalised recommendations